PROGRAM CHAIR
Diana R. Kerwin, MD
Adjunct Assistant Professor, Department of Neurology
University of Texas Southwestern Medical Center
Founder and President of Kerwin Medical Center
Dallas, Texas
FACULTY
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Associate Director, Family Medicine Residency Program
Abington Jefferson Health
Jenkintown, Pennsylvania
PROGRAM OVERVIEW
The PREPARE Clinical Conversations Enduring Program is a case-based educational initiative designed to equip clinicians with the skills to identify and address early cognitive decline in routine practice. Led by experts in primary care and neurology, this program emphasizes the use of validated screening tools, clinical signs and symptoms, and emerging biomarkers to differentiate normal aging from early cognitive impairment. Clinicians will gain expertise in incorporating updated guidelines, conducting meaningful discussions with patients and caregivers, and implementing practical approaches for testing, referrals, and coordinated care management.
TARGET AUDIENCE
This activity is tailored to address the educational needs of healthcare providers, excluding those located in the United Kingdom, who are involved in managing patients with cognitive health concerns. The primary audience includes primary care clinicians and general practitioners (MDs/DOs/NPs/PAs), general neurologists, and geriatricians, with a secondary audience of psychiatrists and OB-GYNs.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Appraise cognitive health screening best practices to differentiate normal aging from early cognitive decline using validated tests, while offering appropriate management strategies and specialist referral
- Justify the use of clinical signs and symptoms, as well as biomarkers, to detect neuropathological changes in cognitive health conditions
- Model the integration of new data and guideline recommendations for cognitive health assessments into clinical practice
- Initiate conversations about cognitive health and cognitive preservation through patient and caregiver discussions and interdisciplinary communication across the cognitive health team
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
ACCME INNOVATION PARTNER DISCLAIMER
Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (eg, name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Speaker | Relationships | Manufacturer |
| Diana R. Kerwin, MD |
Consultant | Roche/Genentech, Eisai, Novo Nordisk |
| Contracted Research | AirBrio, Eli Lilly, Eisai, Roche/Genentech, Acumen, Merck, Bristol Myers Squibb, ProMIS Neurosciences, Amylyx | |
| Neil Skolnik, MD |
Consultant | AstraZeneca, Teva, Lilly, Sanofi, Sanofi Pasteur, GSK, Abbott Laboratories, Novo Nordisk, Astellas Pharma |
| Speakers Bureau | AstraZeneca, Lilly, GSK, Teva, Heartland Pharma, Takeda, Astellas Pharma, Novo Nordisk | |
| Contracted Research | AstraZeneca, GSK, Novo Nordisk, Novartis |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, CEO of Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, Sr VP of Operations for Med Learning Group, has nothing to disclose.
- Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Shilpa Lalchandani, PhD, Medical Director for Med Learning Group, has nothing to disclose.
- Tom Bregartner, MBA, VP of Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Kelly Vicci, RN, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Russie Allen, MM, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
- Emmanuella Foucault, Associate Program Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: January 30, 2026
EXPIRATION DATE: January 30, 2027
Copyright © 2026 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
